BACKGROUND: Vitamin D insufficiency is common in industrialized and developing nations. Recent studies have shown that vitamin D insufficiency is associated with a higher risk of active tuberculosis. Laboratory studies provided a mechanism for this link on the basis of findings that vitamin D metabolites regulate the expression of cathelicidin (LL-37), which is an endogenous antimicrobial peptide with activity against Mycobacterium tuberculosis. Little information is available on the clinical relation between vitamin D, LL-37 concentrations, and disease severity in patients with tuberculosis. OBJECTIVE: The primary objective of the study was to evaluate the relation between vitamin D nutriture, serum LL-37 concentrations, and tuberculosis by using samples stored in the Tuberculosis Trials Consortium serum repository. DESIGN: We measured 25-hydroxyvitamin D [25(OH)D] and LL-37 concentrations in 95 serum specimens from patients with culture-confirmed pulmonary tuberculosis and correlated these concentrations to clinical and demographic variables. RESULTS: The prevalence of vitamin D insufficiency [serum 25(OH)D concentration lt 30 ng/mL] in patients with active tuberculosis was 86% (n = 95) with a mean baseline serum 25(OH)D concentration of 20.4 ng/mL. Factors associated with vitamin D insufficiency were black race and indoor lifestyle. The mean ( plusmn SD) baseline LL-37 concentration was 49.5 plusmn 23.8 ng/mL. Higher LL-37 concentrations correlated with acid fast bacilli sputum smear positivity and weight gt 10% below ideal body weight. Serum vitamin D status of the study subjects did not correlate with serum LL-37 concentrations. CONCLUSION: More prospectively designed studies are needed to evaluate the clinical implications of vitamin D insufficiency in patients with tuberculosis and the utility of circulating LL-37 as a potential biomarker in patients with active tuberculosis disease. The parent trial was registered at clinicaltrials.gov as NCT00023335.
RCT Entities:
BACKGROUND:Vitamin Dinsufficiency is common in industrialized and developing nations. Recent studies have shown that vitamin Dinsufficiency is associated with a higher risk of active tuberculosis. Laboratory studies provided a mechanism for this link on the basis of findings that vitamin D metabolites regulate the expression of cathelicidin (LL-37), which is an endogenous antimicrobial peptide with activity against Mycobacterium tuberculosis. Little information is available on the clinical relation between vitamin D, LL-37 concentrations, and disease severity in patients with tuberculosis. OBJECTIVE: The primary objective of the study was to evaluate the relation between vitamin D nutriture, serum LL-37 concentrations, and tuberculosis by using samples stored in the Tuberculosis Trials Consortium serum repository. DESIGN: We measured 25-hydroxyvitamin D [25(OH)D] and LL-37 concentrations in 95 serum specimens from patients with culture-confirmed pulmonary tuberculosis and correlated these concentrations to clinical and demographic variables. RESULTS: The prevalence of vitamin Dinsufficiency [serum 25(OH)D concentration lt 30 ng/mL] in patients with active tuberculosis was 86% (n = 95) with a mean baseline serum 25(OH)D concentration of 20.4 ng/mL. Factors associated with vitamin Dinsufficiency were black race and indoor lifestyle. The mean ( plusmn SD) baseline LL-37 concentration was 49.5 plusmn 23.8 ng/mL. Higher LL-37 concentrations correlated with acid fast bacilli sputum smear positivity and weight gt 10% below ideal body weight. Serum vitamin D status of the study subjects did not correlate with serum LL-37 concentrations. CONCLUSION: More prospectively designed studies are needed to evaluate the clinical implications of vitamin Dinsufficiency in patients with tuberculosis and the utility of circulating LL-37 as a potential biomarker in patients with active tuberculosis disease. The parent trial was registered at clinicaltrials.gov as NCT00023335.
Authors: Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin Journal: Science Date: 2006-02-23 Impact factor: 47.728
Authors: William J Burman; Stefan Goldberg; John L Johnson; Grace Muzanye; Melissa Engle; Ann W Mosher; Shurjeel Choudhri; Charles L Daley; Sonal S Munsiff; Zhen Zhao; Andrew Vernon; Richard E Chaisson Journal: Am J Respir Crit Care Med Date: 2006-05-04 Impact factor: 21.405
Authors: Christian Wejse; Victor F Gomes; Paulo Rabna; Per Gustafson; Peter Aaby; Ida M Lisse; Paul L Andersen; Henning Glerup; Morten Sodemann Journal: Am J Respir Crit Care Med Date: 2009-01-29 Impact factor: 21.405
Authors: John S Adams; Songyang Ren; Philip T Liu; Rene F Chun; Venu Lagishetty; Adrian F Gombart; Niels Borregaard; Robert L Modlin; Martin Hewison Journal: J Immunol Date: 2009-04-01 Impact factor: 5.422
Authors: Alexandra V Yamshchikov; Nirali S Desai; Henry M Blumberg; Thomas R Ziegler; Vin Tangpricha Journal: Endocr Pract Date: 2009 Jul-Aug Impact factor: 3.443
Authors: Adrian F Gombart; Ishir Bhan; Niels Borregaard; Hector Tamez; Carlos A Camargo; H Phillip Koeffler; Ravi Thadhani Journal: Clin Infect Dis Date: 2009-02-15 Impact factor: 9.079
Authors: Leo Jeng; Alexandra V Yamshchikov; Suzanne E Judd; Henry M Blumberg; Gregory S Martin; Thomas R Ziegler; Vin Tangpricha Journal: J Transl Med Date: 2009-04-23 Impact factor: 5.531
Authors: Adrian R Martineau; Robert J Wilkinson; Katalin A Wilkinson; Sandra M Newton; Beate Kampmann; Bridget M Hall; Geoffrey E Packe; Robert N Davidson; Sandra M Eldridge; Zoë J Maunsell; Sandra J Rainbow; Jacqueline L Berry; Christopher J Griffiths Journal: Am J Respir Crit Care Med Date: 2007-04-26 Impact factor: 21.405
Authors: Nirali S Desai; Nestani Tukvadze; Jennifer K Frediani; Maia Kipiani; Ekaterine Sanikidze; Memorie M Nichols; Gautam Hebbar; Russell R Kempker; Veriko Mirtskhulava; Iagor Kalandadze; Shabnam Seydafkan; Nilay Sutaria; Tai C Chen; Henry M Blumberg; Thomas R Ziegler; Vin Tangpricha Journal: Nutrition Date: 2012-02-02 Impact factor: 4.008
Authors: Jenny E Han; Jessica A Alvarez; Jennifer L Jones; Vin Tangpricha; Mona A Brown; Li Hao; Lou Ann S Brown; Greg S Martin; Thomas R Ziegler Journal: Nutrition Date: 2017-02-27 Impact factor: 4.008
Authors: Nestan Tukvadze; Ekaterina Sanikidze; Maia Kipiani; Gautam Hebbar; Kirk A Easley; Neeta Shenvi; Russell R Kempker; Jennifer K Frediani; Veriko Mirtskhulava; Jessica A Alvarez; Nino Lomtadze; Lamara Vashakidze; Li Hao; Carlos Del Rio; Vin Tangpricha; Henry M Blumberg; Thomas R Ziegler Journal: Am J Clin Nutr Date: 2015-09-23 Impact factor: 7.045
Authors: Vin Tangpricha; Suzanne E Judd; Thomas R Ziegler; Li Hao; Jessica A Alvarez; Anne M Fitzpatrick; Grace A McComsey; Allison Ross Eckard Journal: AIDS Res Hum Retroviruses Date: 2014-05-28 Impact factor: 2.205
Authors: Tara Raftery; Adrian R Martineau; Claire L Greiller; Subrata Ghosh; Deirdre McNamara; Kathleen Bennett; Jon Meddings; Maria O'Sullivan Journal: United European Gastroenterol J Date: 2015-06 Impact factor: 4.623